Intracellular amyloid-␤ peptide (A␤) has been implicated in neuronal death associated with Alzheimer's disease. Although A␤ is predominantly secreted into the extracellular space, mechanisms of A␤ transport at the level of the neuronal cell membrane remain to be fully elucidated. We demonstrate that receptor for advanced glycation end products (RAGE) contributes to transport of A␤ from the cell surface to the intracellular space. Mouse cortical neurons exposed to extracellular human A␤ subsequently showed detectable peptide intracellularly in the cytosol and mitochondria by confocal microscope and immunogold electron microscopy. Pretreatment of cultured neurons from wild-type mice with neutralizing antibody to RAGE, and neurons from RAGE knockout mice displayed decreased uptake of A␤ and protection from A␤-mediated mitochondrial dysfunction. A␤ activated p38 MAPK, but not SAPK/JNK, and then stimulated intracellular uptake of A␤-RAGE complex. Similar intraneuronal co-localization of A␤ and RAGE was observed in the hippocampus of transgenic mice overexpressing mutant amyloid precursor protein. These findings indicate that RAGE contributes to mechanisms involved in the translocation of A␤ from the extracellular to the intracellular space, thereby enhancing A␤ cytotoxicity.
Intracellular amyloid-␤ peptide (A␤) has been implicated in neuronal death associated with Alzheimer's disease. Although A␤ is predominantly secreted into the extracellular space, mechanisms of A␤ transport at the level of the neuronal cell membrane remain to be fully elucidated. We demonstrate that receptor for advanced glycation end products (RAGE) contributes to transport of A␤ from the cell surface to the intracellular space. Mouse cortical neurons exposed to extracellular human A␤ subsequently showed detectable peptide intracellularly in the cytosol and mitochondria by confocal microscope and immunogold electron microscopy. Pretreatment of cultured neurons from wild-type mice with neutralizing antibody to RAGE, and neurons from RAGE knockout mice displayed decreased uptake of A␤ and protection from A␤-mediated mitochondrial dysfunction. A␤ activated p38 MAPK, but not SAPK/JNK, and then stimulated intracellular uptake of A␤-RAGE complex. Similar intraneuronal co-localization of A␤ and RAGE was observed in the hippocampus of transgenic mice overexpressing mutant amyloid precursor protein. These findings indicate that RAGE contributes to mechanisms involved in the translocation of A␤ from the extracellular to the intracellular space, thereby enhancing A␤ cytotoxicity.
␤-amyloid ͉ Alzheimer's disease ͉ mitochondrial dysfunction ͉ p38 MAPK A lzheimer's disease (AD) is a progressive neurodegenerative process characterized by senile plaques, neurofibrillary tangles, and neuronal loss (1, 2) . Deposition of amyloid-␤ peptide (A␤), a 39-43-amino acid peptide derived from the transmembrane amyloid precursor protein (APP), is found in extracellular senile plaque cores and is associated with neurodegeneration in later stages of AD. In contrast, recent studies suggest that accumulation of intraneuronal A␤ may be an early event in the pathogenesis of AD (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . Addition of A␤ to human neuronal-like cells caused significant mitochondrial damage (17) . Furthermore, our recent study revealed that binding of A␤ to A␤-binding alcohol dehydrogenase (ABAD) or cyclophilin D (10, 11) intracellularly triggered events leading to neuronal apoptosis through a mitochondrial pathway (12, 13, 18, 19) . However, mechanisms through which A␤ produced at the plasma membrane and released into the extracellular space reaches the intracellular milieu remain to be elucidated.
Receptor for advanced glycation end products (RAGE) is a multiligand receptor of the Ig superfamily of cell surface molecules (20) (21) (22) . RAGE acts as a counter-receptor for several quite distinct classes of ligands, such as AGEs, S100/calgranulins, HMG1 (high mobility group 1 or amphoterin), and the family of crossed ␤-sheet fibrils/macromolecular assemblies, which activate receptormediated signal transduction pathways. These ligand-receptor interactions are believed to exert pathogenic effects through sustained cellular perturbation in a range of chronic disorders, including the secondary complications of diabetes, inflammation, and neurodegenerative processes (23, 24) . RAGE, a cell surface binding site for A␤ (25) , is expressed at higher levels in an A␤-rich environment (26, 27) . Targeted neuronal overexpression of a wild-type RAGE transgene in AD-type mice also expressing mutant human APP (mAPP) amplified A␤-mediated neuronal dysfunction. The latter was shown by early abnormalities in spatial learning/memory and exaggerated neuropathologic changes not seen in single transgenics (such as transgenics expressing mAPP alone at the same ages). These data support the hypothesis that RAGE might function as a cofactor for A␤-induced neuronal perturbation in AD (28) . Interaction of A␤ with RAGE expressed on brain endothelial cells initiates cellular signaling leading to the trafficking of monocytes across the blood-brain barrier (BBB) (29) . Furthermore, RAGE has been shown to mediate A␤ transport across the BBB and to contribute to pathologic accumulation of the amyloid peptide in brain (30) . Herein, we demonstrate that RAGE contributes to translocation of A␤ across the cell membrane from the extracellular to the intracellular space in cortical neurons. We also present evidence that A␤-initiated RAGE signaling, especially stimulation of p38 mitogen-activated protein kinase (MAPK), has the capacity to drive a transport system delivering A␤ as a complex with RAGE to the intraneuronal space.
Results

Extracellular A␤ Translocates into Mitochondria in Cortical Neurons.
We have recently demonstrated that A␤, endogeneously generated from a mutant APP transgene, interacts with ABAD within mitochondria and leads to apoptosis-like cell death in vivo and in vitro using a murine system (12, 13) . Addition of exogenous A␤, both 1-40 (A␤ ) and 1-42 (A␤ , to culture media caused mitochondrial dysfunction and apoptotic-like cell death in cortical neurons prepared from wild-type and transgenic (Tg) ABAD mice (Fig. S1 ). However, evidence of A␤-induced neuronal perturbation was significantly enhanced in the ABAD-expressing cells, indicating that an enzyme in the mitochondrial matrix (ABAD) appears to exert toxic effects in response to the exogenous A␤. These data suggested the possibility that A␤ added to the extracellular milieu gained access to the intracellular space and, subsequently, interacted with its intracellular target. These findings led us to probe mechanisms through which A␤ gains access to intracellular compartments.
To evaluate cellular uptake of A␤, we first measured levels of intracellular A␤ in neurons treated with the synthetic human A␤ peptides by ELISA using an antibody specific for the human form of A␤ to differentiate it from endogenous mouse A␤. To remove A␤ bound to the cell surface, cells were treated with trypsin for 5 min before harvest for measurement of the intracellular human A␤. As shown in Figs. S2 and S3, intracellular human A␤ content was at background levels in vehicle-treated neurons, whereas levels of intracellular human A␤ were significantly increased in mouse cortical neurons incubated with human A␤ and A␤ . The accumulation of both A␤ and A␤ peptides occurred in a time-(Figs. S2 A and B and S3 A and C ) and dose-dependent (Figs. S2C and S3 A and C ) manner. Biochemical subcellular fractionation further revealed that the majority of the intracellular A␤ was detected in the mitochondria-enriched fractions (Fig. S3F) as compared with plasma membrane (Fig. S3E ) and cytosolic fractions (Fig. S3G) . As a complementary approach, we performed confocal microscopy using double immunofluorescence with antibodies to A␤ and intracellular markers, such as MAP-2 (neuronal marker), NeuN (neuronal marker), Hsp60 (mitochondrial marker), and calnexin (endoplasmic reticulum marker). After exposure (60 min) to human A␤ and A␤ , but not A␤ (Fig. 1H ) and A␤ 42Ϫ1 (Fig. 1I) , neurons displayed immunoreactivity to anti-human A␤ antibody (clone 4G8) in a cytosolic-like distribution, in addition to a cell surface-like staining pattern ( Fig. 1 B, C , G, and H; double staining images with Hoechst 33342, Fig. S4 J and K) . In contrast, immunoreactivity to anti-human A␤ antibody (clone 4G8) preabsorbed with A␤ (Fig. 1E) or to non-immune serum (Fig. 1F) , was background level in the cells exposed to human A␤ . Cells without A␤ treatment also showed no specific staining patterns (Fig. 1 A) . Intracellular A␤ was observed in cells stained positively for two neuronal markers, MAP2 (Fig. 1R) and NeuN (Fig.  1S) . Further analysis using the mitochondrial marker Hsp60 demonstrated extensive colocalization with A␤ epitopes (Fig. 1T ), although to a lesser extent with the endoplasmic reticulum marker calnexin (Fig. 1U) . To confirm localization of A␤ to the intracellular space, we performed immunogold electron microscopy on cultured neurons. Immunogold particles labeled A␤ and were present in the intracellular space, such as the cytosolic compartment and mitochondria, after exposure of neurons to A␤ . In contrast, the number of immunogold particles was significantly diminished in RAGE-deficient (RAGE Ϫ/Ϫ ) neurons (Fig. 2C ), as compared with wild-type (WT) neurons ( Fig. 2 A and B) . Gold particles were virtually absent when cells were treated with vehicle alone (without treatment of A␤, Fig. S5 A and B) or A␤ antibody was replaced by non-immune IgG ( Fig. S5 C and D) . Quantification of the total number of gold particles per field, based on analysis of multiple images, confirmed a significant decrease A␤-immunogold particles in RAGE Ϫ/Ϫ neurons as compared with WT neurons (Fig. 2D ). These data suggest that exogenous A␤ gains access to intracellular compartments, such as mitochondria, and that absence of RAGE reduces A␤ transport to the intracellular compartment. Neurons exposed to 1 M A␤ (Fig. S6 , part 1) and lower concentration (200 nM) of A␤ (Fig. S6 , part 2) showed a similar intracellular distribution of the peptide.
Blockade of RAGE Diminishes A␤ Uptake and A␤-Induced Mitochondrial Dysfunction. To determine the potential role of RAGE in neuronal A␤ transport, the effect of a blocking antibody to the receptor on A␤ uptake and neurotoxicity was examined in mouse cortical neuron cultures. Pretreatment of neuronal cultures with anti-RAGE IgG (N-16) for 2 h attenuated uptake of human A␤ ( Fig. 3A) and A␤ 1-40 -induced mitochondrial dysfunction, at the level of MTT reduction (Fig. S7A ). In contrast, non-immune IgG had no effect on either uptake of A␤ or MTT reduction. To further examine RAGE-dependent neuronal A␤ transport, neurons prepared from RAGE Ϫ/Ϫ mice were used. Neurons lacking RAGE showed a marked decrease in uptake of A␤ (Fig. 3B ) and complete preservation of MTT reduction in the presence of A␤ ( Fig. S7B) . To examine the effect of RAGE on A␤-induced mitochondrial dysfunction, we measured mitochondrial respiratory key enzyme cytochrome c oxidase (COX IV) activity in RAGEdeficient neurons as compared with COX IV activity in WT neurons. After exposure (24 h) to human A␤ (Fig. 3 C and E) and A␤ (Fig. 3 D and F) , but not their reversed sequence peptides, neurons displayed a significant dose-dependent reduction in COX IV activity. Notably, RAGE deficiency completely reversed the A␤ 1-40 -and A␤ 1-42 -induced reduction in COX IV activity ( Fig. 3 E and F) , which is in agreement with the results of MTT reduction activity. These data indicate that RAGE contributes to transport of A␤ from the cell membrane to the intracellular space, and subsequent induction of mitochondrial dysfunction.
A␤/RAGE-Mediated Signaling Contributes to A␤ Transport and Internalization. In many contexts, RAGE appears to function as a signal transduction receptor, activating multiple downstream intracellular pathways (22, 31) . Thus, we sought to determine if RAGEmediated cellular activation of such intracellular mechanisms might impact on neuronal A␤ transport. We started by examining the effect of A␤ treatment on phosphorylation of SAPK/JNK and p38 MAPK. Exposure of neurons to A␤ 1-40 for 10 min did not affect levels of total or phosphorylated forms of SAPK/JNK (Fig. S8A) . In contrast, neurons exposed to A␤ 1-40 displayed a dose-dependent increase in phosphorylated p38 MAPK as compared to vehicletreated controls (Fig. 4 A and D) , although A␤ 1-40 did not affect total protein levels of p38 MAPK (Fig. 4A) . A␤ 1-42 also stimulated p38 MAPK phosphorylation in a similar dose-dependent manner (Fig. S8B) . Activation of p38 MAPK was observed immediately after A␤ 1-40 treatment and for up to 30 min (Fig. 4E) . Pretreatment of neuronal cultures with the p38 MAPK inhibitor SB203580 blocked A␤ 1-40 -stimulated p38 MAPK phosphorylation (Fig. 4B) . Consistent with these data, neurons pretreated with SB203580, but not a SAPK/JNK inhibitor (SP600125), showed strong inhibition of A␤ 1-40 uptake (Fig. 4F ) and MTT reduction in response to A␤ (Fig. S8C) . A role for RAGE in A␤-mediated activation of p38 MAPK was indicated by inhibition of p38 phosphorylation in cortical neurons from wild-type mice exposed to A␤ in the presence of anti-RAGE IgG (N-16) (Fig. 4B ) and in RAGE-deficient cortical neurons derived from RAGE Ϫ/Ϫ mice (Fig. 4C) . Membrane RAGE Acts as an A␤ Carrier and Co-Internalizes with A␤. To determine molecular mechanisms underlying neuronal A␤ transport, we biotinylated neuronal cell surface proteins, incubated the labeled cells with A␤ , and then analyzed internalized biotinylated proteins. First, we assessed the distribution of biotin in labeled cells before A␤ treatment. Cells fixed immediately after biotinylation and permeabilized with detergent displayed a cell surface and focal [the latter were probably surface accumulations of biotin since they were removed by sodium 2-mercaptoethanesulfonate (MesNa) treatment; see below] distribution of the biotin (Fig. S9D) and, as expected, the absence of A␤ (Fig. S9 A and G) . Next, we examined the intracellular distribution of biotin and A␤ in the cells after A␤ treatment. After biotinylation, cells were incubated with vehicle or A␤ 1-40 for 60 min, treated with MesNa (the latter to remove biotin remaining on the cell surface), fixed and permeabilized with detergent. Cells exposed to A␤ 1-40 displayed an overlapping intracellular distribution of A␤ ( Fig. S9 C and I ) and biotinylated-proteins ( Fig. S9 F and I) , while control cells treated with vehicle alone showed no specific signal (Fig. S9 B, E , and H), suggesting that A␤ is able to interact with cell surface proteins. To analyze internalized proteins in cells exposed to A␤, we performed Western blotting. After biotinylation of surface proteins, cells were incubated with vehicle or A␤ 1-40 for 60 min, treated with MesNa, and then whole cell lysates were collected and subjected to immunoprecipitation. Cell lysates contained same amount of total protein, in each case and from both groups, and were reacted with streptavidin followed by SDS/PAGE. Silver staining of gels revealed a broad array of protein bands, especially in cells exposed to A␤ , compared with controls (Fig. S10A) . Interestingly, immunoblotting with anti-RAGE IgG demonstrated Ͼ8-fold more RAGE antigen had been immunoprecipitated from cells exposed to A␤ , compared with non-treated control (Fig.  S10B) . To determine whether RAGE and A␤ were in the cytosol, we performed immunoprecipitation with anti-A␤ IgG-conjugated beads using the cytosolic fraction from neurons exposed to A␤. Such cytosolic fractions were obtained by ultracentrifugation (13, 32) and showed virtually undetectable levels of the membrane marker Na ϩ /K ϩ -ATPase, compared with presence of the latter in whole cell lysates or membrane-enriched fractions (Fig. S10C) . Immunoprecipitation analysis was also applied to cytosolic fractions using anti-A␤ IgG-conjugated beads or non-IgG-conjugated beads as a control for nonspecific binding. SDS/PAGE of these immunopreciptates was followed by immunoblotting with anti-RAGE IgG. While there was only a weak signal with immune precipitates prepared in the presence of non-IgG beads, the immune precipitates prepared with anti-A␤ IgG beads demonstrated a strong immunoreactive RAGE band (Fig. S10D) . Based on image analysis, there was Ͼ4-fold more RAGE antigen detected in the immune precipitates with anti-A␤ IgG beads compared with nonIgG beads. These data are consistent with the hypothesis that A␤ stimulates internalization of RAGE, and that during this process, RAGE and A␤ interact closely.
To further assess possible colocalization of RAGE and A␤, and the spatial topography of these two molecules after internalization of A␤, we performed dual fluorescence confocal microscopy. Incubation of A␤ with neurons for 60 min demonstrated extensive colocalization of epitopes visualized with anti-RAGE and anti-A␤ antibodies (Fig. S11 ).
A␤ Colocalizes with RAGE in Hippocampus of Aged Tg-mAPP Mice.
To extrapolate these findings to the in vivo setting, we turned to a mouse model of AD-like pathology, transgenic mice overexpressing the human APP isoforms (APP695 and APP751/770) with the familial Alzheimer's dementia mutation (Tg mAPP) and A␤. Immunohistochemical studies were performed to colocalize intracellular A␤ and RAGE in brains from 9-to 10-month-old mice after permeabilizing the cell membrane with detergent. Compared with wild-type controls (Fig. S12 A and C) , low power immunofluorescence images of brain sections from aged Tg mAPP mice displayed increased staining for A␤ (Fig. S12B) and RAGE (Fig. S12D) antigens in the hippocampus, especially in the pyramidal cell layer. Plaques in Tg mAPP mice displayed strong staining for A␤ (Fig.  S12B) . High power confocal immunofluorescence images of the hippocampal CA3 region in Tg mAPP mice further demonstrated that A␤ and RAGE co-localized in an apparently intracellular distribution in pyramidal cells (Fig. S12 F, H, and J) .
Discussion
Our studies address a paradigm in which A␤ binding to cell surface RAGE translocates the ligand into the cytosolic compartment. Our in vitro studies show that: (i) exogenous A␤ translocates from the cell surface to the cytosol, with at least some of the peptide eventually localizing in mitochondria; (ii) such translocation is dependent on RAGE, as it is prevented by blocking antibodies to the receptor and does not occur to an appreciable extent in neurons devoid of RAGE (from RAGE Ϫ/Ϫ mice); (iii) RAGE-mediated cellular activation at the level of p38 MAPK has a central role in internalization of the receptorligand complex; and, (iv) the presence of A␤ within the cytosol and mitochondria is associated with functional consequences, including mitochondrial dysfunction. Immunoprecipitation of cytosolic fractions after A␤ treatment showed that RAGE itself interacts closely with A␤ , consistent with the concept that the receptor may be the actual A␤ transporter/carrier. As a counterpart to these observations in cell culture, immunohistochemical studies showed colocalization of A␤ and RAGE in an apparently intracellular distribution in hippocampal pyramidal cells in the brains of AD-type transgenic mice expressing mAPP/A␤.
Increasing evidence points to a role for intraneuronal A␤ in the pathogenesis of early neural dysfunction and AD pathology. Several observations have indicated that APP localizes not only to the plasma membrane, but also to the trans-Golgi network, endoplasmic reticulum, and endosomal, lysosomal, and mitochondrial membranes (5, 7, 33) . Thus, two possible pathways could underlie the accumulation of intraneuronal A␤: (i) A␤ secreted into extracellular space is subsequently taken up by neurons (and/or other cells); and, (ii) A␤ produced intracellularly remains within the neuron. Our results provide insight into the former pathway, which involves neuronal internalization of both A␤ and A␤ . Initially, based on in vitro studies, it was thought that A␤ was more neurotoxic than A␤ , in part because of the propensity of A␤ to form large aggregates and fibrils. However, more recently, it has been appreciated that oligomeric and prefibrillar A␤ and A␤ have similar cytotoxic effects (34) and such soluble forms of A␤ are believed to play a critical role in the pathogenesis of AD. Recent work has demonstrated that oligomeric A␤ , at a concentration of 200 nM, is capable of blocking long-term potentiation at cortical synapses in the hippocampus and entorhinal cortex (10, 28, 35, 36) . Taken together, our findings suggest that via RAGE, neuronal transmembrane transport of A␤ and A␤ carries soluble assemblies of amyloid peptide into the cell.
The present study revealed that intraneuronal accumulation of A␤ could be sustained during exposure to the peptide, especially in mitochondria, as previously reported (10, 12, (37) (38) (39) (40) . Considerable studies over the past decade have emerged indicating that some intracellular enzymes, insulin-degrading enzyme, endothelinconverting enzyme (ECE)-1b and ECE-2, as well as membrane enzymes, such as neprilysin, ECE-1a, ECE-1c, ECE-1d, matrix metalloproteinase (MMP)-2, MMP-3, and MMP-9, can cleave A␤ at either a single or multiple sites and cleavage products of A␤ resulting from such catabolism are less likely to aggregate and are less neurotoxic than A␤ itself (41) . Moreover, a mitochondrial peptidase, PreP peptidasome, has been recently shown to be capable of degrading A␤ (42) . As these various amyloid-degrading enzymes have distinct subcellular localization, A␤ metabolism may influence the subcellular accumulation of A␤ and its neurotoxicity. The mechanism through which intraneuronal A␤ is metabolized will require further study to elucidate.
Recent studies demonstrate that several plasma membrane receptors, such as N-methyl-D-aspartate receptors (14) , ␣7 nicotinic acetylcholine receptors (15) , and low-density lipoprotein receptor-related proteins (LRP) (16) , have the capacity to bind to A␤ and, potentially, promote intracellular accumulation of A␤. Previous studies have shown that RAGE binds monomeric, oligomeric, and even fibrillar forms of A␤ at the neuronal cell surface (22, 27, 43) . Moreover, RAGE promotes A␤-induced neuronal dysfunction in a mouse model of AD-type pathology (28) . Subsequent to A␤ binding to RAGE on the cell surface, we have found that the amyloid peptide is internalized in a RAGE-dependent manner; blocking RAGE or deletion of the receptor attenuates A␤ internalization and A␤-induced mitochondrial dysfunction in cortical neurons. These findings strongly suggest a role for RAGE as a cell surface-binding site and a potential transporter for A␤ which facilitates intracellular transfer of the peptide.
RAGE-ligand interaction has been shown to activate multiple intracellular signaling pathways including the MAPKs (ERK1/2, p38 MAPK and SAPK/JNK), rho-GTPases, phosphoinositol-3-kinase, and the JAK/STAT pathway in various cells (23, 43) . In addition, the RAGE-ligand interaction has been shown to directly cause generation of reactive oxygen species via NADPH oxidases (44) . As a consequence of A␤ϪRAGE interaction, activation of p38 MAPK, SAPK/JNK, and NF-B was observed in sporadic AD cybrids (45) . In addition, Arancio et al. (28) reported increased phosphorylation of CREB, ERK1/2, p38 MAPK, and CaMKII in hippocampal extracts from Tg mice overexpressing RAGE and mAPP. RAGE-dependent activation of p38 signal transduction also plays an important role in A␤-mediated synaptic failure (35, 36) . However, direct links between RAGE-mediated signaling pathways and A␤ neurotoxicity remain to be fully elucidated. The present study indicates that the A␤-RAGE interaction rapidly activates p38 MAPK, but not SAPK/JNK, and further demonstrates a link between activation of p38, intracellular A␤ accumulation, and A␤-induced cytotoxicity in cortical neurons.
In the BBB endothelial cells, RAGE and LRP1 have shown to be critical for regulation of A␤ homeostasis in the central nervous system (46) . RAGE binds soluble A␤ at the apical side of human BBB, and promotes transport of soluble A␤ from blood to brain via endocytosis and transcytosis. These events promote A␤ accumulation in brain parenchyma (29, 47) . Our biotinylation study revealed that A␤ stimulated internalization of neuronal plasma membrane proteins, including RAGE, and that RAGEϪA␤ complex was present intracellularly. These finding suggest that the interaction of A␤ with RAGE activates an endocytosis-like pathway that causes rapid internalization of A␤ϪRAGE complex. Consistent with these in vitro results, recent studies in brains of AD patients (48) and another mouse AD model (49) displayed striking accumulation of A␤ in hippocampal pyramidal cells.
In conclusion, our study demonstrates that A␤ induces a RAGE-dependent pathway that involves activation of p38 MAPK, resulting in internalization of A␤ and leading to mitochondrial dysfunction in cultured cortical neurons. We propose that A␤ internalization may be associated with RAGE-mediated endocytosis and that RAGE itself may act as a carrier in transmembrane A␤ transport. The mechanism through which A␤ gains access to the cytosol and enters mitochondria will require further study to elucidate. Cytosolic A␤ may enter mitochondria through the TOM pathway as recently reported (39) leading to mitochondrial stress. The results of our studies contribute to a growing body of evidence demonstrating that RAGE can act as a receptor magnifying intraneuronal A␤ cytotoxicity. Blockade of RAGE may have a beneficial effect by limiting intracellular accumulation of amyloid in AD brain and serves a potential therapeutic target for AD.
Materials and Methods
For full description of this study's materials and methods, see SI Materials and Methods.
Animals. RAGE knockout (RAGE Ϫ/Ϫ ) mice have been described previously (35, 50) .
Cell Culture. Cortical neurons were prepared from embryos at 17 days of gestation of C57BL/6J mice, transgenic mice overexpressing the human fulllength ABAD (Tg-ABAD mice) and homozygous RAGE Ϫ/Ϫ mutant mice.
Biochemical Determination of Neuronal Perturbation. Neuronal perturbation after A␤ treatment was determined by generation of reactive oxygen species (ROS), mitochondrial membrane potential, caspase activity, DNA fragmentation, MTT reduction, and cytochrome c oxidase (COX IV) activity assays.
Determination of Membrane A␤ Transport. Transport of A␤ into cytosol through the plasma membrane was measured by ELISA and detected by confocal immunofluorescence and immunoelectron microscopies using anti-A␤ IgG.
Measurement of Phospho-MAPKs. A␤-stimulated phosphorylation of SAPK/JNK and p38 MAPK was detected by Western blot analysis or measured by ELISA.
Analysis of Internalization of Membrane Surface Proteins.
Internalization of membrane surface proteins after A␤ treatment was detected by Western blot analysis using biotinylation and immunoprecipitation.
Immunohistochemistry. Immunohistochemistry was executed in hippocampal sections from Tg mAPP mice (9-to 10-month-old) and age-and strainmatched wild-type mice using anti-A␤ IgG and anti-RAGE IgG.
Statistics. Statistical analysis of the experimental data were carried out using GraphPad Prism 4 for Macintosh (GraphPad Software). The significance of differences was determined by a one-way ANOVA, followed by the Dunnett's or Tukey's multiple comparison test for multigroup comparisons. Unpaired t-test was used for two-group comparisons. The criterion for statistical significance was P Ͻ 0.05.
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